Broadcasts

Broadcasts

PharmaVoice – Editors’s Take

August 2013

Thought Leader: Jim Murphy, President and Managing Director of Almac’s Clinical Technologies business unit discusses the importance of the Asia-Pacific region, particularly Singapore and Japan, for market expansion.

Click here to watch the interview featuring Jim Murphy, President and Managing Director (Almac’s Clinical Technologies business unit).

 

Live at CPhi / ICSE - Almac’s key capital investments in US commercial packaging and non-gmp development

October 2012

David Downey, VP Commercial Operations, discusses this years contract pharmaceutical development and manufacturing outsourcing trends, highlighting Almac’s key capital investments in US commercial packaging and non-gmp development to meet growing client demands.

Click here to watch the interview featuring David Downey VP Commercial Operations

 

PharmaVoice – Editors’s Take

26 July 2012

Thought Leader: Jim Murphy, President and Managing Director of Almac’s Clinical Technologies business unit discusses the best practices to running global clinical trials and how the advent of strategic outsourcing is impacting clinical supply management.

Click here to watch the interview featuring Jim Murphy, President and Managing Director (Almac’s Clinical Technologies business unit).

 

Live From Interphex: Commercial Packaging Facility Coming To Pennsylvania

04 May 2012

Almac announces additional details on their new commercial packaging facility opening Fall 2012 in Audubon, Pennsylvania.

Click here to watch the interview featuring David Downey, VP Commercial Operations (Almac’s Pharma Services business unit).

 

15 November 2011

Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business.

Click here to listen to the interview featuring David Downey, VP Commercial Operations (Almac’s Pharma Services business unit).

 

Almac Talks Expansion at Interphex 2011 on Outsourcing-Pharma

20 April 2011

Outsourcing-Pharma spoke with James McGibbon from Almac at Interphex 2011 in New York who cited the recent addition of biopharmaceuticals storage capacity at the global headquarters in Craigavon, Northern Ireland as an example of Almac’s recent growth.

Click here to watch the interview featuring James McGibbon, Director of Business Development (Almac’s Pharma Services business unit).

 

Almac Discusses its Investment in Biocatalysis Lauding Cost and Environmental Benefits on Outsourcing-Pharma

13 October 2010

Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.

Click here to listen to the podcast featuring Tom Moody, head of Almac’s biocatlaysis unit (Almac Sciences business unit).

 

Almac Discusses New Biomarker Service on Outsourcing-Pharma

26th August 2010

Almac says an effective biomarker strategy boosts a drug candidates’ chance of success and can ultimately add value to a developer’s business by opening door to diagnostics.

Click here to listen to podcast featuring Michael Sloan, VP Business Development (Almac’s Diagnostics business unit).

Flash replacement image